April 28, 2022 Price forecast | 2 weeks: -0.61% | 1 month: -1.69% | 3 months: -1.97%


MRNA stock forecast

Our latest prediction for Moderna Inc's stock price was made on the April 28, 2022 when the stock price was at 142.52$.

In the short term (2weeks), MRNA's stock price should underperform the market by -0.61%. During that period the price should oscillate between -8.02% and +9.19%.

In the medium term (3months), MRNA's stock price should underperform the market by -1.97%. During that period the price should oscillate between -25.66% and +20.43%.

Create a solid portfolio with MRNA

Add MRNA to your portfolio and optimize it!


About Moderna Inc

Moderna, Inc is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based on messenger RNA.

At the moment the company generates 18471M USD in revenues.

On its last earning announcement, the company reported a profit of 28.29$ per share.

The book value per share is 4.05$

Moderna Inc website


Three months stock forecastApril 28, 2022


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
18471M 85.80% 13296M 72.00% 12202M 28.29 - - 431M 4.05 13620M -284M 13336M